Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2008 Jun;92(6):864-5; author reply 865-6.

Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions

N Nigam, J Hedaya, W R Freeman
Comment

Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions

N Nigam et al. Br J Ophthalmol. 2008 Jun.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Lux A, Llacer H, Heussen FM, Joussen AM. Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions. Br J Ophthalmol. 2007;91:1318–22. - PMC - PubMed
    1. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–31. - PubMed
    1. Freeman WR, Falkenstein I. Avastin and new treatments for AMD: where are we? Retina. 2006;26:853–8. - PubMed
    1. Falkenstein IA, Cheng L, Morrison VL, et al. Standardized visual acuity results associated with primary versus secondary bevacizumab (Avastin) treatment for choroidal neovascularization in age-related macular degeneration. Retina. 2007;27:701–6. - PMC - PubMed

MeSH terms